pillbase.ru

Columvi

Active substance: glofitamab

Glofitamab

Centralised EU authorisationActive

Marketing holder: Roche Registration GmbH 

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 2
  • Columvi
    SOLUTION, CONCENTRATE · GLOFITAMAB 2.5 mg/2.5mL
    50242-125
    Genentech, Inc.
  • Columvi
    CONCENTRATE · GLOFITAMAB 10 mg/10mL
    50242-127
    Genentech, Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208e-6009-7999-8671-223d4d7f0822,01a12098-bc20-777d-ad30-0abbeab960c7;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005751
Registration status
Active
ATC code
L01FX28
Sources
  • product · EMA · EMEA/H/C/005751 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005751 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005751 · Verified 2026-10-09